Table 3.
Subgroup analysis of the trials that compared IM with CM for PASI score.
| k | MD | 95% CI | Heterogeneity (I2) | Psubgroup | |
|---|---|---|---|---|---|
| Source of investigational medicine | 0.0240 | ||||
| Research institute prescription | 39 | −3.7420 | −4.2580 to −3.2261 | 98.4% | |
| Other conventional medicine | 30 | −2.8494 | −3.4276 to −2.2712 | 95.9% | |
| Formulation type | 0.0116 | ||||
| Decoction | 32 | −2.8951 | −3.3769 to −2.4132 | 95.2% | |
| Other types | 37 | −3.8594 | −4.4331 to −2.2856 | 98.6% |
IM: Integrative medicine; CM: conventional medicine; PASI: psoriasis area severity index.